levofloxacin has been researched along with candesartan cilexetil in 1 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (candesartan cilexetil) | Trials (candesartan cilexetil) | Recent Studies (post-2010) (candesartan cilexetil) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 628 | 151 | 133 |
| Protein | Taxonomy | levofloxacin (IC50) | candesartan cilexetil (IC50) |
|---|---|---|---|
| Type-1 angiotensin II receptor | Oryctolagus cuniculus (rabbit) | 0.2 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 2.4547 | |
| DNA polymerase kappa | Homo sapiens (human) | 7.4 | |
| DNA polymerase iota | Homo sapiens (human) | 6.2 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 0.7244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 other study(ies) available for levofloxacin and candesartan cilexetil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |